The latest closing stock price for Intra-Cellular Therapies as of November 20, 2024 is 85.64.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $4,709 today, roughly 5 times their original investment - a 17.16% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 91.57 on November 11, 2024.
The Intra-Cellular Therapies 52-week high stock price is 93.45, which is 9.1% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 58.14, which is 32.1% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 71.80.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $4,709 today, roughly 5 times their original investment - a 17.16% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 91.57 on November 11, 2024.
The Intra-Cellular Therapies 52-week high stock price is 93.45, which is 9.1% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 58.14, which is 32.1% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 71.80.